B.H Holdings is an Israeli investment company, who establish support and advice to several of the biggest health institutes in Israel. One of the companies is L.E.M Laboratory.

​

L.E.M is the biggest Pathology and Cytology laboratory in Israel, controlling approximately 40% of the market. 

The owners of B.H Holdings, are the Ben-Hur family, leaded by Prof. Herzel Ben-Hur.

​

Professor Herzel Ben-Hur is a Senior Obstetrician, Gynecologist & Gyneco-Oncologist in Merkaz Shamir (Assaf Harofeh) Medical Center in Rishon Letzion, Israel.

​

The C.E.O and partner of B.H Holdings is Eitan Ben Hur.

Eitan Ben-Hur is the former CEO of the largest privately owned Pathology Laboratory in Israel, leading L.E.M laboratory to unprecedented accomplishments and becoming a key player in the health services in the country.

​

Tal Ben-Hur is one of the founders of B.H holdings with over 20 years of International experience, Tal has a vast experience in leading and managing Medical Supply Chains and testing companies and facilities. He co-founded L.E.M Laboratories, one of Israel’s largest renowned pathology lab and has a proven track record in leading and managing teams and complex international projects in multicultural, highly political and individual environments at different levels. Tal was the CEO of AID Genomic Israel that represents The BGI Group in Israel and beforehand was the COO of Varcode a Supply Chain Israeli start-up.
Tal holds a BA in Law and a Diploma in Education from the University of Bar Ilan.

​